Early detection and diagnosis of acute myocardial infarction: the potential for improved care with next-generation, user-friendly electrocardiographic body surface mapping

American Journal of Emergency Medicine

Volumn 25, Issue 9, 2007, Pages 1063-1072

  Lefebvre, Cedric ^a   Hoekstra, James ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHIC BODY SURFACE MAPPING; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; HUMAN; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TECHNOLOGY;

EID: 36048984193     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2007.06.011     Document Type: Article

References (65)

1. American Heart Association. Heart disease and stroke statistics-2007 update (2007), American Heart Association, Dallas, TX
2. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-e171
3. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 44 (2004) 671-719
4. Fibrinolytic Therapy Trialists Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 343 (1994) 311-322
5. Boersma E., Maas A.C., Deckers J.W., et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 348 (1996) 771-775
6. De Luca G., Suryapranata H., Zijlstra F., et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 42 (2003) 991-997
7. De Luca G., Suryapranata H., Ottervanger J.P., et al. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation 109 (2004) 1223-1225
8. Cannon C.P., Gibson C.M., Lambrew C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000) 2941-2947
9. Stone G.W., Cox D., Garcia E., et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 104 (2001) 636-641
10. Cox D.A., Stone G.W., Grines C.L., et al. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial). Am J Cardiol 98 (2006) 331-337
11. Armstrong P.W., Fu Y., Chang W.C., et al. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation 98 (1998) 1860-1868
12. Berger P.B., Ellis S.G., Holmes Jr. D.R., et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation 100 (1999) 14-20
13. McNamara R.L., Wang Y., Herrin J., et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 47 (2006) 2180-2186
14. Collinson P.O., Gaze D.C., Morris F., et al. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria. Ann Clin Biochem 43 (2006) 273-280
15. Fesmire F.M., Christenson R.H., Fody E.P., et al. Delta creatine kinase-MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non-ST-segment elevation acute coronary syndromes. Ann Emerg Med 44 (2004) 12-19
16. Rozenman Y., and Gotsman M.S. The earliest diagnosis of acute myocardial infarction. Annu Rev Med 45 (1994) 31-44
17. Newby K.H., Thompson T., Stebbins A., et al. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes, The GUSTO Investigators. Circulation 98 (1998) 2567-2573
18. Herring N., and Paterson D.J. ECG diagnosis of acute ischaemia and infarction: past, present and future. QJM 99 (2006) 219-230
19. Fesmire F.M., Percy R.F., Bardoner J.B., et al. Usefulness of automated serial 12-lead ECG monitoring during the initial emergency department evaluation of patients with chest pain. Ann Emerg Med 31 (1998) 3-11
20. Welch R.D., Zalenski R.J., Frederick P.D., et al. Prognostic value of a normal or nonspecific initial electrocardiogram in acute myocardial infarction. JAMA 286 (2001) 1977-1984
21. Menown I.B., MacKenzie G., and Adgey A.A. Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. Eur Heart J 21 (2000) 275-283
22. Eriksson P., Gunnarsson G., and Dellborg M. Diagnosis of acute myocardial infarction in patients with chronic left bundle-branch block. Standard 12-lead ECG compared to dynamic vectorcardiography. Scand Cardiovasc J 33 (1999) 17-22
23. Brady W.J., Lentz B., Barlotta K., et al. ECG patterns confounding the ECG diagnosis of acute coronary syndrome: left bundle branch block, right ventricular paced rhythms, and left ventricular hypertrophy. Emerg Med Clin North Am 23 (2005) 999-1025
24. Gula L.J., Dick A., and Massel D. Diagnosing acute myocardial infarction in the setting of left bundle branch block: prevalence and observer variability from a large community study. Coron Artery Dis 14 (2003) 387-393
25. Madias J.E., Sinha A., Ashtiani R., et al. A critique of the new ST-segment criteria for the diagnosis of acute myocardial infarction in patients with left bundle-branch block. Clin Cardiol 24 (2001) 652-655
26. Sgarbossa E.B., Pinski S.L., Barbagelata A., et al. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. N Engl J Med 334 (1996) 481-487
27. Edhouse J.A., Sakr M., Angus J., et al. Suspected myocardial infarction and left bundle branch block: electrocardiographic indicators of acute ischaemia. J Accid Emerg Med 16 (1999) 331-335
28. Newby K.H., Pisano E., Krucoff M.W., et al. Incidence and clinical relevance of the occurrence of bundle-branch block in patients treated with thrombolytic therapy. Circulation 94 (1996) 2424-2428
29. Go A.S., Barron H.V., Rundle A.C., et al. Bundle-branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. Ann Intern Med 129 (1998) 690-697
30. Decker W.W., Prina L.D., Smars P.A., et al. Continuous 12-lead electrocardiographic monitoring in an emergency department chest pain unit: an assessment of potential clinical effect. Ann Emerg Med 41 (2003) 342-351
31. Hedges J.R., Young G.P., Henkel G.F., Gibler W.B., Green T.R., and Swanson J.R. Serial ECGs are less accurate than serial CK-MB results for emergency department diagnosis of myocardial infarction. Ann Emerg Med 21 (1992) 1445-1450
32. Fesmire F.M. A rapid protocol to identify and exclude acute myocardial infarction: continuous 12-lead ECG monitoring with 2-hour delta CK-MB. Am J Emerg Med 18 (2000) 698-702
33. Pfeffer M.A., and Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81 (1990) 1161-1172
34. Miller T.D., Christian T.F., Hopfenspirger M.R., et al. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 92 (1995) 334-341
35. Mak K.H., Moliterno D.J., Granger C.B., et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 30 (1997) 171-179
36. Stranders I., Diamant M., van Gelder R.E., et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164 (2004) 982-988
37. Laskey W.K., Selzer F., Vlachos H.A., et al. Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 90 (2002) 1062-1067
38. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
39. Peterson E.D., Pollack Jr. C.V., Roe M.T., et al. Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4. J Am Coll Cardiol 42 (2003) 45-53
40. Hoekstra J.W., Pollack Jr. C.V., Roe M.T., et al. Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative. Acad Emerg Med 9 (2002) 1146-1155
41. Hoekstra J.W., Roe M.T., Peterson E.D., et al. Early glycoprotein IIb/IIIa inhibitor use for non-ST-segment elevation acute coronary syndrome: patient selection and associated treatment patterns. Acad Emerg Med 12 (2005) 431-438
42. Roe M.T., Parsons L.S., Pollack Jr. C.V., et al. Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarction. Arch Intern Med 165 (2005) 1630-1636
43. Hoenig M.R., Doust J.A., Aroney C.N., et al. Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era. Cochrane Database Syst Rev 3 (2006) CD004815
44. Bavry A.A., Kumbhani D.J., Quiroz R., et al. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature. Am J Cardiol 93 (2004) 830-835
45. Masoudi F.A., Magid D.J., Vinson D.R., et al. Implications of the failure to identify high-risk electrocardiogram findings for the quality of care of patients with acute myocardial infarction: results of the Emergency Department Quality in Myocardial Infarction (EDQMI) study. Circulation 114 (2006) 1565-1571
46. Muller J.E., Maroko P.R., and Braunwald E. Evaluation of precordial electrocardiographic mapping as a means of assessing changes in myocardial ischemic injury. Circulation 52 (1975) 16-27
47. Madias J.E., Venkataraman K., and Hodd Jr. W.B. Precordial ST-segment mapping 1. Clinical studies in the coronary care unit. Circulation 52 (1975) 799-809
48. Lux R.L. Electrocardiographic mapping. Noninvasive electrophysiological cardiac imaging. Circulation 87 (1993) 1040-1042
49. Taccardi B. Body surface distribution of equipotential lines during atrial depolarization and ventricular repolarization. Circ Res 19 (1966) 865-878
50. McMechan S.R., MacKenzie G., Allen J., et al. Body surface ECG potential maps in acute myocardial infarction. J Electrocardiol 28 (1995) 184-190
51. McClelland A.J., Owens C.G., Menown I.B., et al. Comparison of the 80-lead body surface map to physician and to 12-lead electrocardiogram in detection of acute myocardial infarction. Am J Cardiol 92 (2003) 252-257
52. Menown I.B., Allen J., Anderson J.M., et al. ST depression only on the initial 12-lead ECG: early diagnosis of acute myocardial infarction. Eur Heart J 22 (2001) 218-227
53. Ornato J.P., Menown I.B., Riddell J.W., et al. 80-lead body map detects acute ST elevation myocardial infarction missed by standard 12-lead electrocardiography. J Am Coll Cardiol 39 (2002) 332
54. Menown I.B., Allen J., Anderson J.M., et al. Early diagnosis of right ventricular or posterior infarction associated with inferior wall left ventricular acute myocardial infarction. Am J Cardiol 85 8 (2000) 934-938
55. Kornreich F., Montague T.J., and Rautaharju P.M. Body surface potential mapping of ST segment changes in acute myocardial infarction. Implications for ECG enrollment criteria for thrombolytic therapy. Circulation 87 (1993) 773-782
56. Maynard S.J., Menown I.B., Manoharan G., et al. Body surface mapping improves early diagnosis of acute myocardial infarction in patients with chest pain and left bundle branch block. Heart 89 (2003) 998-1002
57. Wung S.F. Discriminating between right coronary artery and circumflex artery occlusion by using a noninvasive 18-lead electrocardiogram. Am J Crit Care 16 (2007) 63-71
58. Morris F., and Brady W.J. ABC of clinical electrocardiography: acute myocardial infarction-Part I. BMJ 324 (2002) 831-834
59. Khaw K., Moreyra A.E., Tannenbaum A.K., et al. Improved detection of posterior myocardial wall ischemia with the 15-lead electrocardiogram. Am Heart J 138 (1999) 934-940
60. Rich M.W., Imburgia M., King T.R., et al. Electrocardiographic diagnosis of remote posterior wall myocardial infarction using unipolar posterior lead V9. Chest 96 (1989) 489-493
61. Casas R.E., Marriott H.J., and Glancy D.L. Value of leads V7-V9 in diagnosing posterior wall acute myocardial infarction and other causes of tall R waves in V1-V2. Am J Cardiol 80 (1997) 508-509
62. Zalenski R.J., Cooke D., Rydman R., et al. Assessing the diagnostic value of an ECG containing leads V4R, V8, and V9: the 15-lead ECG. Ann Emerg Med 22 (1993) 786-793
63. Self W.H., Mattu A., Martin M., et al. Body surface mapping in the ED evaluation of the patient with chest pain: use of the 80-lead electrocardiogram system. Am J Emerg Med 24 (2006) 87-112
64. Owens C.G., McClelland A.J., Walsh S.J., et al. Prehospital 80-LAD mapping: does it add significantly to the diagnosis of acute coronary syndromes?. J Electrocardiol 37 Suppl (2004) 223-232
65. Brady W.J., Hwang V., Sullivan R., et al. A comparison of 12- and 15-lead ECGS in ED chest pain patients: impact on diagnosis, therapy, and disposition. Am J Emerg Med 18 (2000) 239-243